CHEMED CORP (CHE)

US16359R1032 - Common Stock

566.1  -1.9 (-0.33%)

After market: 566.1 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
2.139B
2.87%		2.135B
-0.20%		2.264B
6.06%		2.447B
8.06%
EBITDA
YoY % growth
420.6M
8.40%		404.2M
-3.90%		421.788M
4.35%		519.92M
23.27%
EBIT
YoY % growth
361.5M
9.08%		345M
-4.56%		360.923M
4.62%		433.78M
20.19%
Operating Margin
16.90%16.16%15.94%17.73%
EPS
YoY % growth
19.35
7.02%		19.76
2.12%		21.45
8.55%		23.75
10.73%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		5.76
22.30%
Revenue
Q2Q % growth		603.79M
9.02%
EBITDA
Q2Q % growth		127M
EBIT
Q2Q % growth		105.29M
44.71%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 5.20
7.88%		5.53-0.33-6.05%
Q4 2023
Q2Q % growth		 6.60
22.45%		6.310.294.55%
Q3 2023
Q2Q % growth		 5.32
12.24%		4.950.377.50%
Q2 2023
Q2Q % growth		 4.71
-2.69%		5.14-0.43-8.32%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2024
Q2Q % growth		 589.233M
5.19%		597.38M-8.147M-1.36%
Q4 2023
Q2Q % growth		 585.912M
7.18%		592.51M-6.598M-1.11%
Q3 2023
Q2Q % growth		 564.532M
7.23%		564M532K0.09%
Q2 2023
Q2Q % growth		 553.816M
4.24%		568.16M-14.344M-2.52%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 1.66% 0% 2.19%
Revenue0% 1.16% 0% 1.12%